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Vaccinia virus (vv) and Shope fibroma virus (SFV), representatives of the orthopox and leporipox genera, respectively, 
encode type I DNA topoisomerases. Here we report that the 957-nt F4R open reading frame of orf virus (OV}, a representative 
of the parapox genus, is predicted to encode a 318-aa protein with extensive homology to these enzymes. The deduced 
amino acid sequence of F4R has 54.7 and 50.6% identity with the VV-and SFV enzymes, respectively. One hundred forty 
amino acids are predicted to be conserved in all three proteins. The F4R protein was expressed in Escherichia co/i under 
the control of an inducible T7 promoter, partially purified, and shown to be a bona fide type I topoisomerase. Like the VV 
enzyme, the OV enzyme relaxed negatively supercoiled DNA in the absence of divalent cations or ATP and formed a 
transient covalent intermediate with cleaved DNA that could be visualized by SDS-PAGE. Both the noncovalent and covalent 
protein/DNA complexes could be detected in an electrophoretic mobility shift assay. The initial PCR used to prepare 
expression constructs yielded a mutant allele of the OV topoisomerase with a G-A transition at nt 677 that was predicted 
to replace a highly conserved Tyr residue with a Cys. This allele directed the expression of an enzyme which retained 
noncovalent DNA binding activity but was severely impaired in DNA cleavage and relaxation. Incubation of pUC19 DNA 
with the wild-type OV or VV enzyme yielded an indistinguishable set of DNA cleavage fragments, although the relative 
abundance of the fragments differed for the two enzymes. Using a duplex oligonucleotide substrate containing the consensus 
site for the VV enzyme, we demonstrated that the OV enzyme also cleaved efficiently immediately downstream of the 
sequence CCCTT ~. © 1995 Academic Press, Inc. 
Replication and transcription of double-stranded DNA 
in vivo leads to the accumulation of torsional strain. This 
strain is resolved by topoisomerases which cleave one 
(type I enzymes) or both (type II enzymes) DNA strands, 
form a transient covalent enzyme/DNA complex and 
allow strand passage, and then rejoin the broken 
strand(s). The essential ity of these enzymes in prokary- 
0tes and eukaryotes is underscored by their genetic re- 
dundancy. The biochemical properties of both type I and 
type II enzymes have been thoroughly reviewed (Wang, 
1985; Osheroff, 1989; Champoux, 1990). 
Vaccinia virus (VV), the prototypic orthopoxvirus, en- 
00des a single type I topoisomerase (VV topoi that is 
packaged into virions (Bauer et al., 1977; Fogelsong and 
Bauer, 1984; Shaffer and Traktman, 1987; Shuman and 
Moss, 1987). The enzyme has been well characterized 
and most closely resembles the eukaryotic type I topo- 
is0merases (Bauer et al., 1977; Fogelsong and Bauer, 
1984; Shaffer and Traktman, 1987; Shuman et aL, 1988). 
Sequence data from this article have been deposited with the EMBL/ 
GenBank Data Libraries under Accession No. OVU 12401. 
~To whom correspondence and reprint requests should be ad- 
dressed. 
2Present address, CSlRO Division of Wildlife and Ecology, P.O. Box 
84, Lyneham, ACT, 2602, Australia. 
The predicted and apparent molecular weights of the en- 
zyme are 36,662 and 32,000, respectively (Shuman and 
Moss, 1987; Shaffer and Traktman, 1987), approximately 
one-third the size of the enzymes encoded by S. cerevis- 
iae, S. pombe, and human cells (Uemura et al., 1987; 
Thrash et al., 1985; D'Arpa et al., 1988). Nevertheless, the 
predicted amino acid sequence of the viral enzyme con- 
tains numerous regions of homology which are common 
to all of these enzymes (Shuman and Moss, 1987; Lynn 
et al., 1989; Upton et al., 1990). The inability to isolate VV 
recombinants lacking a topoisomerase gene has been 
taken as evidence that the enzyme is indispensable for 
viral replication (Shuman et al., 1989a). Although the exact 
roles the enzyme plays in the viral life cycle have not 
been determined, it is likely to relieve the torsional stress 
engendered by transcription (Britl and Sternglanz, 1988; 
Liu and Wang, 1987; Schultz eta/., 1992) and DNA replica- 
tion (Kim and Wang, 1989; Wang and Liu, 1990). Additional 
roles in intermolecular recombination (Shuman, 1991a, 
1992) and in the resolution of concatemeric replication 
intermediates to mature genomes have been proposed 
(DeLange and McFadden, 1990). 
Recombinant VV topo can be easily expressed in 
Escherichia coi l  Like the enzyme produced during viral 
infections of mammalian cells (Shaffer and Traktman, 
1987), the recombinant protein relaxes negatively su- 
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percoiled DNA substrates in the absence of an energy 
cofactor (Shuman et aL, 1988; Klemperer and Traktman, 
1993). Relaxation activity is stimulated by magnesium, 
manganese, calcium, cobalt, and spermidine but is inhib- 
ited by copper, zinc, and ATP. Unlike its cellular counter- 
parts, the viral enzyme is resistant to the drug campto- 
thecin (Shuman et aL, 1988). The viral enzyme binds to, 
and cleaves immediately downstream of, the specific tar- 
get sequence 5'-c/TCC-I-i  (Shuman and Prescott, 1990; 
Shuman, 1991b). The 3'-OH of the cleaved strand be- 
comes covalently linked to Tyr 274 of the polypeptide (Shaf- 
fer and Traktman, 1987; Shuman et aL, 1989b). 
In conjunction with the ease of producing recombinant 
enzyme, the small size of the VV enzyme has made it 
an excellent target for genetic dissection. Isolation of 
mutants has been pursued primarily by two strategies= 
site-directed mutagenesis of conserved motifs or selec- 
tion for alleles which have lost the toxicity associated 
with constitutive expression of the wild-type enzyme in 
E. coil No mutants have yet been isolated which fail to 
bind noncovalently to the recognition sequence. How- 
ever, a large number of amino acid substitutions have 
been associated with a reduction or elimination of the 
ability to form the cleaved complex= Gly132-Asp, Gly 132- 
Ser, Thr147-11e, Glyle6-Glu, Lys22°-Asp, LysZZ°-Ile, Lys 22°- 
Asn, Arg223-GIn, Arg223-Glu, Arg223-Gly, Arg223-Lys, Thr 224- 
Gly, Thr224-Pro, Tyr225-Ser, and TyrZZ%Arg (Morham and 
Shuman, 1992; Klemperer and Traktman, 1993). To define 
residues which might be important in the DNA religation 
reaction, mutants which induce an SOS response in host 
bacteria have been sought; alterations of Gly22e-Asn ap- 
pear to diminish rejoining activity (Gupta et aL, 1994). 
As mentioned above, comparison of the VV enzyme 
with other type I topoisomerases has identified highly 
conserved motifs and has guided targeted mutagenesis 
studies. We considered that a comparison with the topo- 
isomerase encoded by off virus (OV), a parapoxvirus, 
might be particularly useful. The life cycle of OV parallels 
that of vaccinia virus. The genomes share many func- 
tional similarities, such as hairpin termini and concate- 
met resolution sequences, the presence of direct and 
inverted terminal repeats, and the overall gene content 
and localization (Mercer et aL, 1987; Fraser et aL, 1990; 
Fleming et aL, 1993). Indeed, the promoters regulating 
OV genes can be recognized by the transcriptional ma- 
chinery encoded by vaccinia virus (Fleming et aL, 1992). 
However, the OV genome has a GC content of 63%, in 
sharp contrast to the 36% GC content of VV. We postu- 
lated that the OV and VV topoisomerases, while likely to 
be highly homologous, might have evolved differences 
conducive to manipulating such dissimilar DNA sub- 
strates in an optimal fashion. 
In this report, we present the complete sequence of 
the OV type I topoisomerase (OV topo) and its successful 
expression in E. co/i. A comparison of its properties with 
those of the vaccinia enzyme is shown, as is the isolation 
of a mutant allele of the OV enzyme which is impaired 
in its ability to cleave and relax DNA substrates. 
MATERIALS AND METHODS 
Preparation of DNA clones 
Genomic OVc/ones. The cloning of the BamHI F frag- 
ment of the OV strain NZ2 into pUC8 (pVU6) has been 
described (Mercer etaL, 1987). A 0.9-kb BamHl/Kpnl flag- 
ment derived from the adjacent BamHI C fragment was 
purified on glass beads (Vogelstein and Gillespie, 1979) 
and cloned into pTZ18R to give the clone pVUDL-TPII. 
C/oning of OV topoisomerase / for expression in E. 
coiL The complete OV topoisomerase I (OV topo) gene 
was amplified by PCR using genomic DNA as a template 
and primers which placed EcoRI, Hindlll, and Ndel sites 
at the 5'-end arld an EooRI site at the 3'-end of the gene. 
The PCR product was cloned into pUC7 and introduced 
into the DH5a strain of E. coiL Plasmid DNA was subse- 
quently isolated from a transformed colony and sub- 
jected to DNA sequence analysis. The DNA sequence 
of this PCR-generated OV topo allele differed from that 
obtained for the genomic allele by a single nucleotide 
change at position 677 that was predicted to replace 
Tyr 2z6 with a Cys residue. This OV topo allele was re- 
cloned as an Ndel/EcoRI b~unt fragment into a pET3 expres- 
sion vector (Studier et aL, 1990) (prepared as an Ndet/ 
BamHI b~unt linear molecule). The blunted ends were gen- 
erated by filling in the overhangs left by restriction diges- 
tion with the Klenow fragment of E. coil polymerase I and 
dNTPs. This construct, designated pET3c/OV¥226C-topo, 
directed the synthesis of a mutant topoisomerase with 
minimal DNA relaxation activity. Generation of a wild- 
type (wt) expression construct was accomplished by re- 
placing the 740-bp BamHI-Sacl fragment from pET3c/ 
OVYzzeC-topo with the corresponding fragment from the 
genomic clone pVUDL-TPII. This pET3c/OV-topo con- 
struct was used successfully to produce active OV topo 
in E. coiL 
Sequencing and enzymes. Restriction endonucleases, 
T4 polynucleotide kinase, T4 DNA ligase, the Klenow 
fragment of E. coil DNA polymerase I, Taq DNA polymer- 
ase, and Calf intestinal alkaline phosphatase were pur- 
chased from Boehringer-Mannheim (Mannheim, Ger- 
many and Indianapolis, IN) or New England Biolabs (Bev- 
erly, MA) and used according to the manufacturer's 
instructions. The sequence of the BamHI F fragment 
which contains the promoter region and the first 109 nt 
of the OV topo gene has been reported (Fleming et al., 
1993). The remainder of the gene sequence was ob- 
tained from pVUDL-TPI1. Clones for sequencing were 
constructed by subcloning fragments of pVUDL-TPI1 into 
M13 vectors and sequenced by the dideoxy chain termi- 
nation method of Sanger (Sanger etaL, 1977)in microtiter 
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plates using a T7 DNA polymerase kit supplied by Amer- 
sham Corp. (Arlington Heights, IL). Regions containing 
ambiguities and compressions were resolved by using 
kits containing Taq DNA polymerase (Pharmacia Biotech, 
Inc., Piscataway, N J, and Amersham Corp.). Gel electro- 
phoresis, autoradiography and sequence data analysis 
have been described previously (Mercer et aL, 1987; Fra- 
ser et al., 1990). The consensus sequence was derived 
from individual sequences giving a redundancy of over 
5. Sequence analysis of the PCR-derived topo allele used 
for expression purposes (see above) was performed us- 
ing a Sequenase kit according to the manufacturer's in- 
structions (United States Biochemical, Cleveland, OH). 
Expression of wt and mutant alleles of OV topo and 
wt VV topo 
The viral topoisomerases were overexpressed in E. 
coil HMS174 transformants carrying pET3c/VV-topo 
(Klemperer and Traktman, 1993), pET3c/OV-topo, or 
pET3c/OV¥226c-topo. Cultures were grown in tryptone- 
phosphate (2% bacto-tryptone, 0.2% Na2HPO4, 0.1% 
KH2P04, 0.8% NaCI, and 1.6% yeast extract) supple- 
mented with 0.2% maltose and 50 #g/ml ampicillin until 
a density of 4 x 108 cells/ml was obtained. Expression 
of the tope genes from the upstream T7 promoter was 
initiated by infection with XCE6 (Studier et al., 1990). After 
20 rain of absorption at room temperature (multiplicity of 
infection, 10 PFU/ml), infected cultures were shaken at 
37 ° for 90 min. Cells were collected by centrifugation, 
washed in M9 buffer (42 mM Na2HPO4, 22 mM KH2PO4, 
8.6 mM NaOl, 18.7 mM NH4CI, 2 mM MgSO4, and 0.2% 
glucose) and then metabolically labeled for 5 min at 37 ° 
in M9 buffer supplemented with 625 #M of each amino 
acid excluding methionine. [35S]Methionine (DuPont- 
NEN, Boston, MA) (specific radioactivity of 1200 Ci/mmol) 
was added to a final concentration of 23 nM. Cells were 
collected by centrifugation, subjected to a cycle of 
freeze-thawing, and resuspended at 20 times the origi- 
nal culture density in Buffer A (50 mM Tris, pH 7.4, 1 mM 
EDTA, 1 mM DI-i-, and 10% glycerol) containing 50 mM 
NaCI. The resulting lysates were sonicated five times 
for 30 sec each while on ice. Debris was removed by 
centrifugation for 30 rain at 14,000 rpm in a Brinkmann 
microfuge. The topoisomerases were partially purified 
from the supernatants as described below. Whole cell 
extracts of uninduced (harvested just prior to XCE6 infec- 
tion) or induced cultures were prepared as described 
above with omission of the final centrifugation. Aliquots 
representing 0.5 ml of the original culture were analyzed 
bySDS-PAGE (Laemmli, 1970). The total protein concen- 
tration within the whole cell and soluble extracts, and 
the phosphocellulose (p-cell) eluants described below, 
were determined with a colorimetric Bio-Rad (Hercules, 
CA) protein assay, using lysozyme as a standard. 
Purification of type t topoisomerases 
The topoisomerases were partially purified from bacte- 
rial lysates using a batch p-cell method of purification, 
as described previously (Klemperer and Traktman, !993). 
The p-cell resin was equilibrated with Buffer A containing 
0.25 M NaCI and a 50% slurry was prepared. Clarified 
bacterial lysates (see above) (0.6 ml) were mixed with 
an equal volume of the 50% slurry and incubated with 
end-over-end rotation for 15 min at 4 °. The p-cell resin 
was collected by centrifugation at 2000 rpm for 2 min in 
a Brinkman microfuge and the supernatant was dis- 
carded. A similar elution with 0.6 ml of Buffer A containing 
0.5 M NaOl was performed. Finally, topo was eluted into 
0.6 ml of Buffer A containing 1 M NaCI. The salt content 
of'this fraction was reduced to less than 2 mM NaCI by 
dialysis against Buffer A. This was used as the source 
of enzyme for all assays. 
The partially purified fractions were resolved on SDS- 
polyacrylamide gels that were subsequently stained with 
Coomassie blue; the concentration of topoisomerase 
was estimated by comparison to known amounts of car- 
bonic anhydrase. The concentration of VV, wt OV, and 
OV ¥226c topoisomerases in the final fractions was esti- 
mated to be 225, 150, and 19 ng/#l, respectively. 
Topoisomerase assays 
Relaxation of a supercofled DNA substrate. Enzymatic 
assay of the VV and QV topoisomerases involved moni- 
toring the relaxation of supercoiled plasmid (pUC19) DNA 
(Shaffer and Traktman, 1987; Klemperer and Traktman, 
1993). To rid pUC19 of contaminating impurities prior 
to inclusion in relaxation assays, the DNA was passed 
through an Elutip membrane (Schleicher and Schuell, 
Keene, NH) according to the manufacturer's instructions. 
Standard relaxation reactions (20 ffl) contained 150 ng 
of pUC19 DNA, 40 mM Tris, pH 7.4, 0.1 M NaCI, 2.5 
mM EDTA, and varying amounts of the partially purified 
topoisomerases. Dilutions of the p-cell eluants were pre- 
pared in a buffer containing 0.5 mg/ml BSA, 30 mM KPO4, 
pH 7.0, 0.5 mM Dq-F, and 5% glycerol. Following a 15- 
min incubation at 37 °, reactions were quenched with 5 
#1 of sample buffer containing 50% glycerol, 2% SDS, 0.1 
M EDTA, and bromophenol blue. Samples were resolved 
by electrophoresis on horizontal 1.3% agarose gels cast 
and run in 0.5x TBE (50 mM Tris, 41.5 mM boric acid, 
and 0.5 mM EDTA) at 2.5 V/cm for 12 hr. Gels were 
stained with ethidium bromide and photographed under 
uv illumination. 
Preparation of radiolabeled DNA substrates. For label 
transfer assays, plasmid DNA was nick translated (Rigby 
eta/., 1977) using all four ~-32p-labeled dNTPs to a spe- 
cific radioactivity of >5 X 107 cpm/#g. Qligonucleotide 
substrates for cleavage and gel shift assays were pre- 
pared with an Applied Biosystems 391 DNA synthesizer 
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(Foster City, CA). The 24-mer oligo duplex synthesized 
contains the VV topo consensus cleavage site (c/TCC-Iq-;) 
(Shuman and Prescott, 1990; Shuman, 1991b) 
5' CGT GTC GCC CTT  ~ ATT  CCG ATA GTG 
GCA CAG CGG GAA TAA GGC TAT CAC.  
The 5' terminus of the upper (cleaved) strand was 
radiolabeled using [~,32p]ATP and T4 polynucleotide ki- 
nase. The labeled oligonucleotide was subjected to gel 
purification prior to hybridization to the lower strand. To 
radiolabel the 3' end of the upper (cleaved) strand of 
the DNA duplex, the following oligos were allowed to 
hybridize, 
5' CGT GTC GCC CTT  ~ ATT  CCG ATA G 
GCA CAG CGG GAA TAA GGC TAT CAC.  
The upper strand was radiolabeled using the Klenow 
fragment of DNA polymerase, [~-32P]-i-I-P and 0.2 mM 
dGTP. The duplex was gel-purified and used as substrate 
for the formation of covalent and noncovalent opoisom- 
erase-DNA complexes, as described below. 
For the generation of end-labeled pUC19 DNA, the 
restriction enzyme Xbal was used to cleave the plasmid 
at a unique site. The 3'-termini of both strands were 
then radiolabeled using the Klenow fragment of DNA 
polymerase, [a-32p]dCTP and 0.2 mM-i-I-P. Subsequent 
digestion with EcoRI allowed the purification of a singly 
radiolabeled DNA fragment of 2.66 kb. 
Label transfer. Visualization of the covalent protein- 
DNA intermediate. Two different DNA substrates, pUC19 
and a 24-mer oligo duplex, were used for detection of 
the covalent DNA-topoisomerase I intermediate. Partially 
purified, dialyzed p-cell eluants were used as the source 
of topoisomerase. Reactions (20 #1) performed with the 
first substrate contained 2.5 pmol of each partially puri- 
fied enzyme, 45 fmol of uniformly radiolabeled pUC 19, 
20 mM-I-ris, pH 7.4, 0.4 mM EDTA, 0.4 mM D-I-i-, and 4% 
glycerol. Following a 15-min incubation at 37 °, DNA not 
covalentiy associated with topoisomerase was digested 
by addition of DNase I and MgCI2 (15 #l) to final concen- 
trations of 300 #g/ml and 15 mM, respectively (Shaffer 
and Traktman, 1987). After an additional 20 min of incuba- 
tion at 37 ° , reactions were stopped by the addition of 
SDS-sample buffer, heated at 100 ° for 5 min, and fraction- 
ated by electrophoresis on SDS-12% polyacrylamide 
gels. Gels were fixed and dried and the DNA-topoisom- 
erase I intermediates were visualized by autora- 
diography. 
For the oligonucleotide duplex substrate, reactions (20 
ffl) containing 6 pmol of each partially purified topoisom- 
erase, 100 fmol of 5'-32P-labeled 24-mer oligo duplex, 20 
mM Tris, pH 7.4, 12.5 mM NaCI, 0.4 mM EDTA, and 0.4 
mM Dqq- were incubated at 37 ° for 15 min. Reactions 
were quenched by the addition of SDS-sample buffer, 
heated at 100 ° for 5 min, and fractionated by etectropho- 
resis on SDS-t2% polyacrylamide gels. 
DNA cleavage assay. End-labeled pUC19 DNA was 
used to compare the cleavage specificities of the VV 
and OV topoisomerases (Shaffer and Traktman, 1987; 
Shuman and Prescott, 1990). Reactions (20 #1) containing 
either 12 pmol of ©V topo or 8 pmol of VV topo, 14 fmol 
of 3'-labeled pUC19, 20 mM Tris, pH 7.4, 0.25 mM D-i-T, 
0.25 mM EDTA, and 2.5% glycerol were incubated at 370 
for 5 min. Following the addition of 1% SDS, samples 
were heated at 100 ° for 3 min, immediately cooled on 
ice and supplemented with NaOH (30 mM), EDTA (2 
mM), and glycerol (10%). Samples were fractionated 
through horizontal alkaline agarose gels (1.2% agarose 
containing 30 mM NaOH and 2 mM EDTA) by electropho- 
resis at 2 V/cm. Gels were dried by blotting and examined 
by autoradiography. 
Visualization. of covalent and noncovalent protein- 
DNA complexes by native gel electrophoresis. Reactions 
(20 #l) contained 11 and 16 pmol of OV and VV topo, 
respectively, 300 fmol 3'-32p-labeled 24-mer oligo duplex, 
10 mM Tris, pH 7.4, 0.4 mM DTT, 0.4 mM EDTA, and 4% 
glycerol. Following a 5-min incubation at 37 °, glycerol 
was added to 10% and samples were fractionated at 40 
through nondenaturing polyacrylamide gels (5% acryl- 
amide, 0.25% bisacrylamide) cast and run in 0.25x TBE. 
Electrophoresis was performed in the cold at 15 V/cm. 
The gels were examined by autoradiography. 
To compare the size of the cleaved products, 10-#1 
reactions containing 8.5 pmol of topo I, 300 fmol 3'-32p - 
labeled 24-mer oligo duplex, 25 mM Tris, pH 7.4, 0.5 mM 
D-I-T, 0.5 mM EDTA, and 5% glycerol were incubated at 
37 ° for 5 min. Following the addition of formamide (to 
45%) and TBE (to 1 x), samples were heated at 100° for 5 
min and fractionated on urea-polyacrylamide gels (50% 
urea, 20% acrylamide, and 1% bisacrylamide, cast and 
run in 1X TBE). Gels were examined by autoradiography. 
RESU LTS 
Mapping and sequence analysis of the OV topo gene 
Open reading frame (ORF) F4R, potentially encoding 
the OV topo, had previously been identified at the right 
end of the centrally located BamHI F fragment and the 
sequence of 109 bp at the 5'-end determined (Fleming 
etaL, 1993). The cleavage sites of a number of restriction 
endonucteases were mapped in the adjacent BamHI C 
fragment and a convenient BamHI/Kpnl fragment, poten- 
tially large enough to contain the remainder of the gene, 
was cloned and sequenced. The sequence of 157 nt of 
the BamHI F fragment, and the 1024 BamHI/Kpnl frag- 
ment, is shown in Fig. 1. To ensure that there was only 
a single BamHI site (and no additional sequence) be- 
tween the BamHI F and C fragments, a fragment con- 
taining the gene was amplified using PCR. The resulting 
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~H~C, B D F C A IK  
(I1"11 " I -  ~1 [ "' I , I I )  
I I I 
BamHl BamH[ Sacl KpnI 
p\nJfi pXn3 DL 'TP l l  
, , , ID . _ . , , .1~ 
F4R 
C1R 
F3R > 
221 K A A A C K K ~ F4R > 
1 M R A L 
1 AAGGCCC-CCGCCTC-CAAGAAGTAGGCGCACTA/.ATAGCGAGGCTC~GTATGC~GGCC-CTG 
5 H L S D G K L F F D K E L T Q P V P D D 
61 CAC CTGTCAGACGSCAAACTTT~TTTGA CAAGGAGCTC~ACGCAGC C -~ CC CCGA C~AC 
25 N P A Y A V L A K I R I P P H L S D V V 
121 AA CC CCC-CGTACGC TGTCCTTGCGAAGATCCGGATCCCA C~CACCTCT CG~TGTGGT C 
45 V Y E ~ D L E S A Q Q G L I F V G R D A 
181 GT GTACGAG CAGGACCTCGAGTCT GCCCAGCAGGGC TCATCTTCGTCGGGCGCGACGCC 
65 K G R K Q Y F Y G R G H V E R R T A V R 
241 AAGGGCC~JAAAGCAGTACTTCTACGGGCC~CG GACACGTGGAGCGCCGCACGGCCGT CCGC 
85 N A V F V R V K R V M N K I N A F I D D 
301 AACG C CGTGTTCGTGCGCGTGCACCG C GTCATGAACAAGATAAACC-CC TTCATC GA CGAC 
i0~ H L A S G S E A E A Q M A A F L L M E T 
361 CACCT CGCCT CCGGCAGCGAGC~CCGAC-~ CAGATC~3CCG CCTTCCT~CATCKgA@ACG 
125 S F F I R V G K T ~ Y ~ R E S G T V G M 
421 AGCTTCTTCATCCGCGTCGGCAAGACGCC~CTACGAC4DGCGAGA~CCGT~TG 
145 L T L R N K ]~ L A E A E G G E E I R V A 
481 CTCACGCTC-CGCAACAACCACCTCGCCGAGGCCGAGGGCGGTGAGGAGATCCGCGTCC-CC 
165 F V G K D R V A H E F A V R E G Q R L F 
541 TTCGTGGGCAAGGACCGAGTCGCGCACGAGTTTGC CGTC~CGA GGGGCAGCGGCTCTTC 
i~5 A A L R R L W D P G A P D R L L F D R L 
601 GCGGCGCTGCGTC GGCTCTGGGA CCCGGGCGCG CCCGACAGC-CTC~GTT CGACCGGC TG 
205 S E R R V Y T F M R R F G I R V K D L R 
661 AGCGAGCGC G CGTGTACACCTT CATGCGACGCTTCGG CATCOSCGTCAAC~3ACCTGCC~C 
225 T y G V N Y T F L Y N F W S N V R S L E 
721 ACCTACGC=CGTGAACTACACCTTCCTGTACAACTTCT~TCCAACGTGCGCTCGCTGGAG 
245 P R P S V K S b I C T S V R Q T A E T V 
?~I CCGCGTCCCTC GTGAAGT CGCTCAT CTGCAC CT COGTGCGGCAGACCGC CGAGACGGTG 
265 G H T P S I S R S A Y M A T A V L E L V 
~&i ~=GCACACGCCCTCGATCTCGCGCAGCGCCTACATC4~CCACCGCGGTGCTCGAGCTCGTC 
285 R D G A F L D R V A A T D T L D D V V D 
901 AGGGA~TTCCTGC~CAGAGTCGCCGCCACCGACACGCTCGAOGACTTCG~VgGAC 
CIR > 
1 M D E A L R V A 
305 I V V D Y V N ~ S E Q V N C- * 
961 ATCGTCGTGGACTATGTAAATAACT CTGAGCAGGTAAATGGATGAGGOGCTG C CGTGGC 
9 A R V V D G L R P L D V A V C L A Q L R 
1021 G~CGCGCGTCGTGGA CGGGCTCCGGC G CTGGACGTC~ CC~TGTGTCTCG C~CAGCTGCG 
29 G A A P E R R F P A L D E C S G E A F L 
1081 CGGAGCCGCGCCCGAGCGCCGCTTCCCGCCGCTCGACGAGTGCTCCGGCGAGGCCTTCCT 
49 D F ~ E A G G D V A S R Y 
1141 GGACTT TGA~TTCGCCC43CGGGGACGTGGCGTCGC G TAC C 
Fie. 1. Map location and sequence analysis of the QV F4R ORF. The 
BarnHI restriction endonuclease cleavage site map for OV strain NZ2 
is shown at the top of the figure. The expanded map below it shows the 
relative positions of restriction endonuclease cleavage sites relevant to 
the DNA manipulations undertaken (see Materials and Methods). Be- 
low and to the same scale as the expanded map are the positions and 
designations of the plasmids used in the analyses and below that the 
relative locations of the F4R ORF and the 5'-end of the ORF designated 
01F{ The arrows indicate the orientation of transcription ofthese ORFs. 
The nucleotide sequence ncompassing F4R and the 5'-end of C1R is 
fragment was cloned and the sequence across the 
BamHI junction confirmed. 
The F4R ORF extends from the BamHI F fragment into 
the SamHI C and is 957 nt in length. The ORF is predicted 
to encode a protein of 318 aa, 4 aa larger than the tope- 
isomerases encoded by the VV H6R and Shope fibroma 
virus (SFV) D2 genes (Shuman and Moss, 1987; Upton 
et al., 1990). The predicted molecular weight of OV topo 
is 36,182. Alignment of the deduced amino acid se- 
quences of the three poxviral genes using CLUSTAL 
(Higgins and Sharp, 1988) shows a high degree of homol- 
ogy, with t40 aa (44%) being invariant in all three proteins 
(Fig. 2). A comparison of the OV protein with that of VV 
gave an identity of 54.7% with conservative changes ac- 
counting for an additional 32.9%. With SFV, the identity 
was 50.6% with 34% conservative changes. The SFV and 
VV sequences are somewhat more closely related, being 
61% identibal with an additional 15% conservative 
changes (Upton et al., 1990). The active site Tyr present 
at residue 274 in VV and 273 in SFV is conserved in ©V 
at residue 275. 
F4R is likely to be expressed late in infection as it is 
preceded by the late poxvirus transcription motif, TAAAT, 
13 nt upstream of the predicted initiation codon. The 
sequence from the 3'-end of the putative topoisomerase 
I gene to the downstream Kpnl site was translated in all 
six frames, revealing one frame (C1R) predicted to en- 
code 61 aa with 33% identity to the SFV ORF D2, and 
16% identity to the VV (Copenhagen strain) ORF H7R. 
These SFV and VV ORFs also lie immediately down- 
stream of the respective topoisomerase genes. A differ- 
ence between C1R and its counterparts in VV and SFV 
is that its 5[-end overlaps the 3'-end of the topoisomer- 
ase gene by 5 nt as a consequence of the longer topo- 
isomerase coding region. 
Overexpression and purification of OV DNA 
topoisomerase 
To demonstrate that the F4R ORF does indeed encode 
a DNA topoisomerase I, the gene was overexpressed in 
E. co/i using the T7 RNA polymerase-driven pET vector 
system (Studier eta/., 1990). The topoisomerase genes 
were induced by infection of pET/VV-topo (Klemperer and 
Traktman, 1993) and pET/OV-topo transformants with 
XCE6. When soluble lysates of induced cultures were 
analyzed by SDS-PAGE, abundant protein species with 
shown below the maps. The sequence from nt 1 to 157, which repre- 
sents the 3'-terminus of the OV BamHI fragment, has been published 
previously (Fleming et a/., 1993) and is equivalent to nts 3192 to 3348 
of the DNA sequence reported in that publication. The deduced amino 
acid sequences of the carboxy-terminus of ORF F3R, the complete F4R 
ORF, and the amino-terminus of ORF C1R are shown above the nt 
sequence. The putative late transcriptional initiation sites for F4R and 
ClR are underlined. 
208 KLEMPERER ET AL 
orftopo 
vactopo 
shopetopo 
i MRALHLSDGKLFFDKELTQPVPDDNPAYAVLAKIRIPPHLSDVVVYEQDLESAQQGLIFV 
i MRALFYKDGKLFTDNNFLNPVSDDNPAYEVLQ[4VKIPTHLTDVVVYEQTWEEALTRLIFV 
i MRAFTYKDGKLYEDKELTIPVHCSNPTYEILKHVKIPSHLTDVIVYEQTYEQSLSRLIFV 
orftopo 
vactopo 
shopetopo 
60 GRDAKGRKQYFYGRGHVERRTAVRNAVFVRVHRVMNKINAFIDDHLA-SGSEAEAQMAAF 
60 GSDSKGRRQYFYGKMHVQNRNAKRDRIFVRVYNVMKRINCFINKNIKKSSTDSNYQLAVF 
60 GLDSKGRRQYFYGKMHVQRRNSARDTIFIKVHRVIDKIHKFIDDTIEHKN-DVLFQLGVF 
orftopo 
vactopo 
shopetopo 
120 LLMETSFFIRVGKTRYERESGTVGMLTLRNKHLAEAEGGEEIRVAFVGKDRVA/4EFAVRE 
121 MLMETMFFIRFGKMKYLKENETVGLLTLKNKHIEISP--DEIVIKFVGKDKVSHEFVVHK 
120 MLMETSFFIRMGKVKYLKENDTVGLLTLKNKNIVREN--RKILIHFVGKDKIIHNFTVHS 
orftopo 
vactopo 
shopetopo 
180 GQRLFAALRRLWDPGAPDRLLFDRLSERRVYTFMRRFGIRVKDLRTYGVNYTFLYNFWSN 
179 SNRLYKPLLKLTDDSSPEEFLFNKLSERKVYECIKQFGIRIKDLRTYGVNYTFLYNFWTN 
178 SNRLYKPLLRLIGRKEPDSFLFHKLSEKKVYKAVQQFGIRLKDLRTYGVNYTFLYNFWTN 
..**. .* .* . *. .**,.***..** *************************** 
orftopo 
vamtopo 
shopetopo 
240 VRSLEPRPSVKSLICTSVRQTAETVGHTPSISRSAYMATAVLE-LVRDGAFLDRVAATDT 
239 VKSISPLPSPKKLIALTIKQTAEVVGHTPSISKRAYMATTILE-MVKDKNFLDVVSKT-T 
238 VKSLNPIPPIKKMISTSIKQTADIVGHTPSISKI{AYIANTVLEYLTHDSELINTIRDI-S 
orftopo 299 LDDFVDIVVDYVNNSEQVNG 
vactopo 297 FDEFLS IVVD}{VKSSTDG- - 
shopetopo 297 FDEFIRLITDYITNTQTV-- 
. * . * .  . . * . . 
FIG. 2. Alignment of the deduced amino acid sequences of poxvirus type I topoisomerases. The amino acid sequences of the OV (orftopo), VV 
(vactopo) (Rosel et aL, 1986; Goebel et aL, 1990; Shuman and Moss, 1987), and SFV (shopetopo) (Upton et aL, 1990) type I topoisomerases, deduced 
from the respective DNA sequences, were aligned using the program CLUSTAL (Higgins and Sharp, 1988). Amino acid residues common to all 
sequences (*) and residues that are similar (.) are marked below the alignments. 
apparent molecular masses of 32 and 35.5 kDa were 
seen, representing the VV (closed circle) and OV topo- 
isomerases (open circle), respectively (Fig. 3A). Unequiv- 
ocal identification of these species as the overex- 
pressed proteins was obtained when a comparison of 
cultures pulse-labeled pre- and postinduction with [35S]- 
methionine was made (Fig. 3B). The anomolously rapid 
migration of the VV protein, which has a predicted molec- 
ular mass of 36.7 kDa, has been seen before (Shaffer 
and Traktman, 1987; Shuman eta/., 1988; Klemperer and 
Traktman, 1993). 
The level of expression of OV topoisomerase was 
about half of that detected for the VV enzyme. Although 
VV and OV topoisomerases have 54.7% amino acid iden- 
tity, the codon usage is quite different as a result of the 
vastly different GC content. This variable may affect the 
efficiency of translation within E. coil Because of the 
reduced level of expression, we found it desirable to 
maximize the solubility of the OV topo. About 50% of the 
DNA topoisomerase produced was soluble when cul- 
tures were grown in LB medium. The use of an enriched 
growth medium, such as tryptone-phosphate, has else- 
where been shown to increase the solubility of overex- 
pressed proteins by limiting inclusion body formation 
(Moore et al., 1993). Culturing of our pET-topo trans- 
formants in this enriched medium similarly increased the 
fraction of target protein recovered in the soluble fraction 
(data not shown); this protocol was followed for all further 
experiments. 
OV and VV topoisomerases were partially purified from 
soluble extracts by batch purification on p-cell resin. Both 
proteins bound tightly to the resin, with 1 M NaCI re- 
quired for elution. The eluants were highly enriched 
for the respective topoisomerase proteins (Fig. 3A, lanes 
4 and 8) and were used for all further biochemical 
analyses. 
Comparison of VV and OV activities 
Relaxation ofsupercoiled DNA. The ability to relax neg- 
atively supercoiled DNA is the definitive assay for topo- 
isomerase activity. Supercoiled substrates migrate more 
rapidly than relaxed products, permitting the clear resolu- 
tion of the two species on agarose gels. The inclusion 
of EDTA in our relaxation assays ensured that any activity 
observed reflected the VV and OV enzymes, because the 
E. coil enzymes have a strict requirement for a divalent 
cation (Wang, 1985; Champoux, 1990). The relative spe- 
cific activities of the partially purified W and OV enzymes 
were assessed by endpoint dilution, assays contained 
2.5 pmol, 0.5 pmol, 0.1 pmol, or 20 fmol of topo per reac- 
tion (Fig. 4). The VV and OV topoisomerases were shown 
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FIG. 3l Visualization of overexpressed and partially purified OV and VV topoisomerases. HMS174 transformants carrying the pET/VV-topo or pET/ 
0V-tope piasmids were induced by infection with XCE6 and harvested as described under.Materials and Methods. Lysates were analyzed on 12% 
SDS-polyacrylamide gels. (A) Proteins visualized by staining with Coomassie brillant blue dye; (B) an autoradiograph of lysates prepared from 
cultures metabolically labeled with [3%]methionine as described under Materials and Methods. Whether lysates were prepared from cultures 
containing the pet/VV-topo r pet/OV-topo plasmid is indicated above the relevant lanes. The lanes contain the following samples~ lanes 1 and 5, 
whore cell lysates from uninduced cultures (15#g protein); lanes 2 and 6, whole cell lysates prepared at 90 min after induction with XCE6 (33 #g 
protein); lanes 3 and 7, soluble lysates prepared from induced cultures (29 #g protein); lanes 4 and 8, enriched topoisomerase preparations purified 
0y phosphocellulose chromatography (8 fig protein). The concentrations of theVV and OV topoisomerases within the p-cell eluants were estimated 
to be 225 and 150 ng/#l, respectively. The VV (closed circle) and OV (open circle) topoisomerase species are indicated to the right of each panel. 
The lane marked mw contains protein standards whose molecular weights (X10 -~) are indicated at the left. 
VV OV 
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FJG. 4. Relaxation of supercoiled DNA by OV and VV topoisomerases. 
Partiarly purified preparations of the VV and OV DNA topoisomerases 
were assayed for their ability to relax supercoiled DNA. Reactions 
:0ntaining 150 fmol pUC19 and various dilutions of the phosphocellu- 
10se-purified enzymes were incubated at 37 ° for 15 min, quenched, 
and fractionated by electrophoresis through agarose gels. DNA was 
visualized by uv illumination after staining with ethidium bromide. A 
series of four reactions is shown for both the VV and QV topoisomer- 
ases. The amount of enzyme assayed decreases from left to right in 
each series; the four reactions shown contained 2.5, 0.6, 0.1, and 0.02 
pro01 of the relevant enzyme. A control in which no phosphocellulose 
eluant was added to the reaction (-) is also shown. The positions to 
which relaxed (rel) and supercoiled (sc) DNA species migrated are 
hdicated to the right. The material seen in the control reaction that 
cemigrates with the relaxed product represents small amounts of 
ncked, circular DNA that is present in the initial substrate. 
to relax supercoi led DNA to a s imi lar extent within this 
concentrat ion range. 
Visualization of the covalent DNA-topoisomerase in- 
termed/ate using pUC19. Eukaryotic type I topo isomer-  
ases form a covalent complex with DNA in which the 
enzyme is covalently bound to the 3' phosphoryl  group 
at the site of c leavage (Champoux, 1990). VV tope is 
unusual among eukaryotic topo isomerases  in that the 
covalent DNA/topo isomerase complex  is stable enough 
to be trapped by the addit ion of a protein denaturant. 
This complex  can be visual ized by the transfer of radioac- 
tivity from a labeled DNA substrate to the enzyme (Shaffer 
and Traktman, 1987). In contrast, visualization of the co- 
valent complex  formed by the human topo isomerase re- 
quires the inclusion of pharmacologica l  agents which 
inhibit the DNA rel igation reaction, forcing an atypical 
accumulat ion of the covalent protein/DNA intermediate. 
To assess the abil ity of the ©V tope to form the covalent 
intermediate, the enzymes were incubated with uniformly 
32P-labeled pUC19. Proteins were fract ionated by SDS-  
PAGE, and the protein/DNA adducts were visual ized by 
autoradiography (Fig. 5A). The intermediates formed by 
both the VV and OV tope migrated as doublets. The OV 
intermediates migrated more s lowly than those formed 
by the VV enzyme, consistent with the difference in the 
observed electrophoret ic  mobi l i t ies of the overexpressed 
proteins (Fig. 3). From these data we conclude that the 
QV enzyme is mechanist ical ly  s imi lar  to the VV tope in 
its abil ity to form a stable covalent intermediate, 
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FiG. 5. Formation of the covalent enzyme/DNA intermediate and gen- 
eration of DNA cleavage products using a radiolabeled pUC19 sub- 
strate. (A) Covalent intermediates were formed by label transfer f om 
nick-translated pUC19 to the VV or OV topoisomerase I. Each reaction 
(20 #l) contained 2.5 pmol of partially purified topoisomerase I and 45 
fmol of radiolabeled pUC19. After a 15-min incubation at 37 °, the excess 
DNA was digested with DNase I. The samples were fractionated by 
SDS-12% PAGE and visualized by autoradiography. A control in which 
no phosphocellulose eluant was added (-) is also shown. The lane 
marked mw contains ~4C-labeled protein standards whose molecular 
weights (Xl0 -3) are indicated at the left. (B) Analysis of VV and OV 
topoisomerase cleavage specificities using a linearized pUC19 DNA 
substrate containing a 3'-radiolabel on one DNA strand. Reactions 
containing 14 fmol of radiolabeled pUC19 DNA and either 12 pmol of 
OV topoisomerase or 8 pmol of VV topoisomerase were incubated at 
37 ° for 5 min. Products were resolved by electrophoresis under denatur- 
ing conditions and visualized by autoradiography. The source of the 
partially purified nzyme is indicated above each lane (©V and VV); 
cleavage products denoted a, b, and c are indicated to the right. A 
control reaction in which no phosphocellulose eluant was added is 
also shown (-). Lane m represents radioiabeled DNA standards whose 
sizes in nucleotides are indicated to the left. 
0 V and VV DNA topoisomerases yield similar cleavage 
patterns when incubated with end-labeled pUC19 DNA. 
Because of the difference in GO content between the 
OV and VV genomes, we considered it worthwhile to 
determine whether or not the two viral enzymes cleave 
DNA at different recognition sequences. To locate the 
sites of strand cleavage, 3'-radiolabeled pUC19 DNA 
was used as a substrate. Upon cleavage at a given site, 
the topoisomerase remains covalently associated with 
the nonradiolabeled fragment, and therefore the mobility 
of the labeled fragments is not affected. Following a brief 
incubation of substrate and enzyme, SDS was added to 
trap the cleaved complexes (and prevent religation) and 
the cleavage products were analyzed on denaturing alka- 
line agarose gels. incubation with either poxviral DNA 
topoisomerase resulted in the production of three main 
cleavage products (a, b, and c) which migrated more 
rapidly through the gel than the uncleaved substrate (Fig. 
5B). The products generated by both enzymes had indis- 
tinguishable mobilities, suggesting that the enzymes 
bind to and cleave the same sites within the DNA sub- 
strate. Product "a" was most abundant when cleavage 
was performed with OV topo, whereas "b and c" were 
the predominant products generated by VV topo. 
OV topo binds to and cleaves an oligonucleotide du- 
plex containing the VV topo consensus cleavage site. The 
apparent commonality of the preferred cleavage sites of 
the VV and OV topos was investigated further by studying 
their interactions with an oligonucleotide substrate con- 
taining the consensus site for VV topo recognition and 
cleavage. The autoradiograph of an SDS-PAGE gel 
shown in Fig. 6A depicts the labeled protein/DNA inter- 
mediates (arrows) formed during cleavage of this 5'-ra- 
diolabeled oligo duplex. It is apparent hat the OV enzyme 
cleaves this substrate with high efficiency. As was seen 
when the assay was performed with a radiolabeled plas- 
mid substrate (Fig. 5A), the covalent intermediate formed 
by the OV enzyme migrates more slowly than that gener- 
ated by the VV tope. 
Native gel electrophoresis was also used to visualize 
the interactions between the enzymes and the oligo sub- 
strate. This gel-shift assay permits the visualization of 
both the covalent DNA/protein intermediate and the non- 
covalent complex whose formation precedes catalysis 
(Morham and Shuman, 1992; Klemperer and Traktman, 
1993). When an oligonucleotide duplex is radiolabeled 
at the 3'-end of the cleavable strand, the labeled DNA 
fragment is released upon cleavage and migrates more 
rapidly than the noncovalent complex or the free sub- 
strate. The autoradiograph shown in Fig. 6B illustrates 
the formation of both types of complex by the VV and 
OV enzymes. Although the apparent molecular weight of 
the OV protein is greater than that of the VV protein, the 
noncovalent complex formed by the OV topoisomerase 
migrated more rapidly than the VV complex. The struc- 
ture of the noncovalent complexes formed by the two 
proteins may therefore be somewhat different, affecting 
their electrophoretic mobilities under these assay condi- 
tions. The radiolabeled strand released upon cleavage 
and covalent complex formation is indicated near the 
bottom of the gel. Although a lower level of cleavage 
product was seen with the OV enzyme in the experiment 
shown in Fig. 6B, cleavage levels comparable to that 
seen with VV topo were more usual. To confirm that 
the OV and VV enzymes cleaved at precisely the same 
position within the oligonucleotide substrate, the radiola- 
beled cleavage fragments were examined on high reso- 
lution denaturing gels (Fig. 60). The 12-nt fragments re- 
leased by the two enzymes had indistinguishable lectro- 
phoretic mobilities. In sum, these data demonstrated that 
the OV enzyme recognized and cleaved the optimal tar- 
get sequence of the VV topoisomerase. 
OV ¥226c contains a point mutation which alters the 
enzymatic activity of the enzyme 
As described above (see Materials and Methods), our 
initial cloning of a PCR-derived OV-topo allele yielded a 
mutant with a reduced ability to relax supercoiled DNA. 
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FiG. 6. Noncovalent and covalent interactions between the OV and VV topoisomerases and a radio/abeled eligonucleotide substrate. A 24-mer 
01igonucleotide uplex which contains the VV topoisomerase I consensus cleavage site (CClq-F ~) was radiolabeled at the 5'- or 3'-terminus of the 
upper (cleaved) strand and used in reactions containing partially purified VV or Q  topoisomerases (indicated above each lane). Lanes marked - 
represent controls in which no enzyme was added. (A) DNA-topoisomerase covalent intermediates were formed between the 5'-labeled oligo 
duplex and topoisomerase I and visualized following fractionation on SDS-12% polyacrylamide gels. Reactions contained 6 pmol of each partially 
purified topoisomerase and 100 fmol of 5'-radiolabeled 24-mer oligo duplex. The arrows to the right of the autoradiograph denote the covalent 
DNA-topoisomerase complexes formed by the two enzymes. (B) Covalent and noncovalent DNA-topoisomerase complexes were formed between 
the 3'-rediolabeled oligo duplex and topoisomerase I and visualized following resolution through nondenaturing 5% polyacrylamide gels cast and 
run in 0.25X TBE. Reactions contained 300 fmol of 3'-radiolabeled 24-mer oligo duplex and 11 pmol of the OV topoisomerase or i6 pmol of the 
VVtopoisomerase. Symbols to the right of the autoradiograph identify each species as representing the radiolabeled (*) substrate with or without 
bound topoisomerase (circle) and before or after topoisomerase-mediated cleavage. (C) The 3'-radiolabeled fragments released upon cleavage of 
the oligonucleotide substrate by the OV and VV topoisomerase were examined by high-resolution urea-acrylamide lectrophoresis. Reactions 
contained 8.5 pmol of VV or OV topoisomerase, as indicated, and 300 fmol of 3'-radiolabeled 24-mer oligo duplex. The sizes of the labeled DNA 
strands are indicated to the right of the autoradiograph. 
Both the wt (OV) and mutant allele of the OV topoisomer- 
ase (OV Y226°) were shown to produce a protein of appar- 
ent molecular weight 35,500 (Fig. 7). The mutation within 
the 0V Y2260 allele reduced both the solubil ity and the 
accumulation of the protein, although sufficient soluble 
enzyme was purified using the batch p-cell protocol to 
all0w a comparative analysis (Fig. 7). OV ¥226c topoisomer- 
ase showed an approximately 25-fold reduction in its 
ability to relax supercoi led DNA relative to the wt OV 
enzyme (Fig. 8A). A similar decrease in activity was seen 
when the enzymes were assayed for their ability to form 
a covalent intermediate with radiolabeled pUC 19 DNA 
Fig. 8B). The OV Y22ec enzyme was not deficient in its 
ability to bind DNA noncovalently, however, as demon- 
strated both by gel shift and filter binding analyses (data 
not shown). Therefore, the mutation affects the ability of 
the enzyme to cleave DNA, reducing the amount of cova- 
lent enzyme/DNA intermediate formed. The mutation in 
this allele is an A to G transition at nt 677 of the open 
reading frame. The Tyr 226 residue affected lies within a 
region which is highly conserved in many type I topo- 
ieomerases (Fig. 8C). The analogous domain of VV tope, 
including the corresponding Tyr residue, has been exten- 
sively mutagenized and shown to be involved in DNA 
cleavage/covalent intermediate formation (Klemperer 
and Traktman, 1993). 
DISCUSSION 
The autonomy of poxvirus replication from host func- 
tions is reflected in the cytoplasmic localization of the 
infectious cycle. Poxviruses encode most, if not all, of 
the proteins required for the regulated transcription and 
replication of the viral genome (Moss, 1990; Traktman, 
1990a,b, 1991). Because both of these processes perturb 
DNA topology, the discovery that the prototypic Orthopox- 
virus, vaccinia, encodes and encapsidates a type I topo- 
isomerase was not unanticipated (Bauer et aL, 1977; 
Shaffer and Traktman, 1987; Shuman and Moss, 1987). 
Shope fibroma virus, a Leporipoxvirus, encodes a type I 
topoisomerase with 61% identity to that of VV (Upton et 
al., 1990). Here we report the DNA sequence, overex- 
pression, and biochemical characterization of the topo- 
isomerase encoded by orf virus, a Parapoxvirus. The en- 
zyme is encoded by the 957-bp F4R ORF, which initiates 
within the BamHI F fragment of the OV genome and 
extends into the adjacent BamHI C fragment. The gene is 
predicted to encode a protein of 318 aa with a molecular 
weight  of 36,182. 
Extensive homology is apparent upon comparison of 
the topoisomerases encoded by the representatives of 
these three poxvirus genera. QV and VV topoisomerases 
display 64.7% identity and 34% conservative changes. OV 
212 
200 
A 
I 
mw 1 2 
96 
68 
43 
29 
KLEMPERER ET AL. 
B 
OV OVyzzs c OV OVyzzs c 
I I  I I I I  I 
3 4 5 6 7 8 1 2 3 4 5 6 7 8 
FiG. 7. Visualization of overexpressed and partially purified OV ¥22ec topoisomerase. HMS174 transformants carrying the pET/QV-topo or pET/ 
OV¥22eC-topo plasmids were induced by infection with XCE6 and harvested as describea under Materials and Methods. Lysates were analyzed on 
12% SDS-polyacrylamide gels; whether samples were prepared from cultures carrying the wild-type (OV) or mutant (OV¥2~Bc) topoisomerase alleles 
is marked above the relevant lanes. (A) Proteins visualized by staining with Coomassie brillant blue dye; (B) an autoradiograph of lysates prepared 
from cultures metabolically labeled with [3~S]methionine as described under Materials and Methods. The lanes contain the following samples, lanes 
1 and 5, whole cell lysates from uninduced cultures; lanes 2 and 6, whole cell lysates prepared at 90 min after induction with XCE6; lanes 3 and 
7, soluble lysates prepared from induced cultures; lanes 4 and 8, enriched topoisomerase preparations purified from soluble lysates of induced 
cultures by phosphocellulose chromatography. Lanes 5--8 contained approximately 11, 29, 26, and 6/~g of protein, respectively. The concentration 
of OV ¥22ec topoisomerase within the enriched preparation (lanes 8) was estimated to be 19 ng//~l. The amount of protein analyzed from the lysates 
obtained from pET/QV-topo transformants (lanes 1-4) was the same as that described in the legend to Fig. 3. The wild-type and mutant 0V 
topoisomerase species are indicated to the right of each panel (open circle). The lane marked mw contains protein standards whose molecular 
weights (X10 -3) are indicated at the left. 
and SFV topoisomerases show 50.6% identity and 34% 
conservative changes. A comparison of the amino acid 
compositions of the OV and VV enzymes provides a vivid 
illustration of how genomic GO content affects codon 
usage and amino acid composition. For example, the OV 
enzyme has only 11 Lys residues, encoded by AAA/G, 
whereas the VV enzyme has 34. in contrast, the OV en- 
zyme contains 34 Arg residues, encoded by CGN (31 
examples) or AGA/G, whereas the VV enzyme only con- 
tains 15. The OV enzyme contains 29 Ala residues (GCN), 
whereas only 9 are found within the VV enzyme; 20 Gly 
residues (GGN) are contained within the OV enzyme, but 
only 11 in the VV enzyme. Conversely, the VV enzyme has 
20 lie (AUA/O/u) and 20 Asn (AAC/u) residues, whereas 
the OV enzyme contains only t 1 of each. Despite these 
dissimilarities, the proteins share several blocks of ex- 
tensive identity which may elucidate which regions of the 
protein are essential for DNA binding and/or catalysis. A 
role for these regions in catalysis has in some cases 
been confirmed by mutational analysis (Morham and 
Shuman, 1990, 1992; Klemperer and Traktman, 1993). By 
analogy to other enzymes (Lynn et al., 1989; Shuman et 
al., 1989b; Upton et aL, 1990), we can predict that Tyr 27e 
of the OV DNA topoisomerase I is the residue involved 
in covalent linkage to the cleaved DNA substrate. The 
motif surrounding this residue is SRSAY; the VV and 
SFV enzymes contain a SKRAY motif, whereas the S. 
cerevisae active site is contained within the sequence 
SKINY. 
As is the case with the VV and SFV topoisomerase 
genes, the F4R ORF is preceded by a late poxvirus pro- 
moter. No F4R transcripts have yet been detected in OV- 
infected cells. A topoisomerase-specific transcript has 
only recently been found in VV-infected cells (Soos and 
Traktman, unpublished observations) after earlier at- 
tempts were unsuccessful (Rosel et al., 1986), suggesting 
that this enzyme may in general be expressed at very 
low levels. The DNA sequence downstream of the 0V 
ORF F4R is predicted to encode the NHz-terminus of an 
ORF denoted C1R. Given the parallels in the organization 
of the OV and VV genomes (Fleming et aL, 1993), it is 
not unexpected that this QRF shows some homology 
to the VV H7R and SFV D20RFs, which likewise lie 
downstream of the respective topoisomerase genes. 
Definitive proof that the putative OV topoisomerase 
gene encodes a type I topoisomerase was demonstrated 
upon overexpression of the OV F4R protein in E. coil 
The protein produced had an apparent molecular weight 
of 35,500, in good agreement with that predicted from the 
deduced amino acid sequence. The recombinant protein 
was partially purified and shown to catalyze the relax- 
ation of supercoiled DNA with a specific activity equiva- 
lent to that seen for the VV enzyme. 
The covalent protein/DNA intermediate formed by the 
OV enzyme during DNA relaxation could be visualized 
without the addition of pharmacological inhibitors of DNA 
religation. This property of forming a stable intermediate 
has previously been a distinguishing feature of the VV 
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Re. 8. Analysis of the DNA relaxation activity of the Y226C mutant of OV topoisomerase. (A) Partially purified preparations of the wild-type (OV) 
and mutant OV (OV ¥226c) DNA topoisomerases were assayed for their ability to relax supercoiled DNA. Reactions were performed as described in 
the Iegend to Fig. 4. For each enzyme, a series of four dilutions were assayed; from left to right, the reactions shown contained 4, 0.8, 0.16, and 
0.03 pmol of enzyme. Reaction products were fractionated by electrophoresis through agarose gels, stained with thidium bromide, and visualized 
by uv illumination. Photographs of the stained gels are shown. A control in which no phosphocellulose eluant was added to the reaction, - ,  is 
also shown. The positions to which relaxed (rat) and supercoiled (sc) DNA species migrated are indicated. (B) Covalent intermediates were formed 
by label transfer from nick-translated pUC19 to the enzyme. Briefly, each reaction contained 4.3 pmol of partially purified topoisomerase and 22 
fm01 of radielabeled pUC19. After a 15-min incubation t 37°, the excess DNA was digested with DNase I. Samples were fractionated by SDS-12% 
PAGE and visualized by autoradiography. The enzyme used is indicated above each lane. Lane mwcontains ~4C-labeled protein standards whose 
molecular masses (x10 -3) are indicated at the left. (C) The mutation in OV ¥226c topoisomerase maps within a region whose amino acid sequence 
is highly conserved among eukaryotic DNA topoisomerases. Shown is an amino acid alignment of topoisomerases as previously described (Shuman 
and Moss, 1987; Lynn eta/., 1989; Upton eta/., 1990)= S. cerevisiae (SO), 6'. pombe (SP), human (HS), Shope fibroma virus (SFV), vaccinia virus (VV), 
and off virus (QV). The position of the relevant Tyr residue within the amino acid sequence of each topoisomerase is shown to the right. The 
descending arrow denotes the amino acid substitutions at this residue which have been studied. The Cys substitution shown is the OV topoisomerase 
mutation described in this report. The other substitutions shown were introduced into the VV topoisomerase by site-directed mutagenesis. Enzymes 
containing the Phe (Shuman et al., 1989b), His, and Trp (Klemperer and Traktman, 1993) substitutions maintain wt levels of relaxation and cleavage 
activity (act), while the Ser and Arg (Klemperer and Traktman, 1993) substitutions lead to r duced, intermediate (int) levels of activity. The Cys 
substitution reported here for the OV enzyme also leads to an intermediate level of relaxation and cleavage activity. Within the figure, all amino 
acids are designated according to the single letter code. 
enzyme which is not shared by other eukaryotic enzymes 
(Shaffer and Traktman, 1987). The impact of adding a 
variety of cations on the formation of the covalent inter- 
mediate was investigated (data not shown). Covalent ad- 
duct formation was  abol ished for both the OV and VV 
topoisomerases upon the inclusion of 5 mM ZnSO4. In- 
clusion of other divalent cations had sl ight but equivalent 
effects on the two enzymes. These data reinforce the 
conclusion that the two poxviral enzymes have indistin- 
guishable mechan isms of action, 
Our demonstrat ion that the two enzymes preferential ly 
recognized and cleaved the same DNA sequence pro- 
vided the most compel l ing evidence of the similarity be- 
tween these enzymes, Both enzymes recognized and 
cleaved immediate ly  3' of the sequence CCC-I-F within 
a 24-mer o l igonucleot ide duplex substrate. That the two 
enzymes cleaved at precisely the same posit ion was 
shown by high resolution e lectrophoresis  of the c leavage 
products. The sequence within this substrate conforms 
to the previously defined consensus sequence for the VV 
enzyme= c/TCCq-F~ (Shuman and Prescott, 1990; Shuman, 
1991b). This exper iment  indicates that the OV enzyme 
can utilize this sequence, but does not address whether  
such a sequence is optimal. An indication of the c leavage 
sites preferred by the enzyme was  obtained by util izing 
an end-labeled, 2.66-kb DNA substrate. Three major 
cleaved fragments were observed after incubation of the 
substrate with either the OV or VV enzymes. That the 
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same products were seen provides strong evidence that 
the enzymes share a preferred recognition site. Because 
detection of a given fragment can reflect cleavage at a 
high affinity site and/or the lack of cleavage at sites proxi- 
mal to the radiolabel, it is difficult to translate the data 
obtained into a ranking of cleavage sites. Therefore, the 
fact that the relative abundance of the three products 
observed was different for the two enzymes is difficult 
to interpret precisely. Our conclusion is that the core 
recognition site of the OV and VV enzymes is the same, 
but that the flanking sequences which provide an optimal 
context may be distinct for the two enzymes. 
The initial step in generating our ©V tope expression 
construct was the cloning of a PCR-derived copy of the 
F4R ORF into a pUC vector and the introduction of this 
cloneinto the DH5~ strain of E. coi l  The plasmid recov- 
ered from such a transformant contained a point mutation 
at nt 677 which was predicted to replace Tyr 226 with a 
Cys residue. The protein encoded by this allele was sub- 
sequently shown to have severely reduced enzymatic 
activity. Based on previous experience, we believe that 
the recovery of this allele was not fortuitous but reflected 
the toxicity of the wild-type allele when expressed at a 
basal level from a promoter within the pUC plasmid. We 
and others (Upton etaL, 1990; Fernandez-Beros and Tse- 
Dinh, 1992; Countryman and Traktman, unpublished ob- 
servations) have shown that even low levels of constitu- 
tive expression of the VV or SFV topoisomerases can be 
inhibitory to growth. We have also shown that pUC/topo 
plasmids do direct the expression of some active enzyme 
within E. coil even when no obvious promoter lies imme- 
diately upstream of the tope gene; the same is true for 
pET plasmids in uninduced bacteria. Activity was evinced 
by the predominance of relaxed DNA isomers within 
plasmid preparations; such relaxed DNA is not found 
within plasmids containing no insert or truncated or mu- 
tant alleles of the enzyme (Klemperer and Traktman, 
1993). We therefore believe that the G-A  transition within 
the OV ¥2260 allele arose either during PCR or spontane- 
ously within E. coil and was selected for on the basis of 
reduced toxicity. 
The Tyr residue affected in this mutant, OV-topo ¥226c, 
lies within a region which is highly conserved among 
eukaryotic type I topoisomerases (Fig. 8C). This region, 
including the analogous Tyr residue of the VV topoisom- 
erase (Tyr 22E) has been the target of extensive site di- 
rected mutagenesis (Klemperer and Traktman, 1993). Re- 
placement of Tyr 225 with a Phe (Shuman et al., 1989b), 
His, or Trp (Klemperer and Traktman, 1993) residue did 
not alter enzyme activity in vitro, implying that an aromatic 
residue at this position may be sufficient. However, re- 
placement with either a Ser or Arg residue resulted in 
an enzyme with altered activity (Klemperer and Traktman, 
1993). Although relaxation activity was ~>50% of that of 
the wt enzyme, partially relaxed isomers were visible. 
These enzymes also displayed a temperature-sensitivity, 
the ratio of the DNA relaxation activity seen at 50 vs 250 
was reduced by 25-fold relative to the wt enzyme. In 
addition, covalent adduct formation was reduced to 10- 
20% of wt adduct formation when pUC19 was used as 
the DNA substrate. The alteration of OV myr 226 to a Cys 
residue in the mutant described in this report impairs 
enzyme activity more than other mutations described, 
since relaxation activity was shown to be reduced by 
more than 25-fold at 37 °, Covalent adduct formation was 
severely inhibited in this mutant. Minimal covalent adduct 
was visible when pUC 19 was used as the substrate and 
adduct formation was reduced relative to the wt OV tope 
when the 24-mer oligonucleotide duplex substrate was 
used. The ability of this enzyme to bind DNA noncova- 
lently was hot affected, however, consistent with our pre- 
vious studies of VV tope alleles carrying mutations at 
this residue or within this conserved region. 
The studies reported here underline the structural and 
functional similarities between the type I topoisomerases 
encoded by three genera of poxviruses. The overall se- 
quence homology is widespread and extensive, and the 
most conserved regions are likely to highlight catalyti- 
cally active domains. Given the almost complete diver- 
gence of the nucleotide composition of the VV and OV 
genomes, it was unanticipated that the VV and OV topo- 
isomerases would target the same consensus sequence 
for recognition and cleavage. It is tempting to speculate 
that the stretch of pyrimidines which constitute the topo- 
isomerase recognition sequence, °/TOC-I-i-~, has been 
conserved among poxviruses of different genera to ac- 
commodate the GC vs AT richness of the Parapoxvirus 
and Orthopoxvirus genera, respectively. Likewise, the 
conservation of mechanistic features as well as the 
shared target sequence provides a further stimulus to 
unravel the specific role(s) of these enzymes within the 
poxviral life cycle. 
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